Clinical asthma syndromes and important asthma mimics

Respiratory Care

Volumn 53, Issue 5, 2008, Pages 568-580

  King, Christopher S ^a   Moores, Lisa K ^b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Asthma; Asthma, etiology; Asthma, genetics; Asthma, mimics; Phenotypes; Vocal cord dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; HISTAMINE; TRIAMCINOLONE;

ACETYLSALICYLIC ACID INDUCED ASTHMA; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGY TEST; ASTHMA; ATOPY; BICYCLE ERGOMETRY; BRONCHOSPASM; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; DIZZINESS; DRUG MEGADOSE; EOSINOPHIL; EOSINOPHILIC ASTHMA; EXERCISE INDUCED ASTHMA; FLUSHING; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LUNG FUNCTION TEST; MENSE RELATED ASTHMA; MORBIDITY; NEUTROPHILIC ASTHMA; OCCUPATIONAL ASTHMA; ONSET AGE; PAUCIGRANULOCYTIC ASTHMA; PHENOTYPE; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; SIDE EFFECT; SKIN TEST; SPIROMETRY; TREADMILL ERGOMETRY; VOCAL CORD DISORDER; VOICE CHANGE; CYTOLOGY; DYSPNEA; EOSINOPHILIA; FEMALE; LARYNX DISORDER; MENSTRUAL CYCLE; METABOLISM; NEUTROPHIL; PATHOPHYSIOLOGY; REVIEW; SPUTUM; VOCAL CORD;

AGE OF ONSET; AIRWAY OBSTRUCTION; ASTHMA; ASTHMA, EXERCISE-INDUCED; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EOSINOPHILIA; FEMALE; HUMANS; LARYNGEAL DISEASES; MENSTRUAL CYCLE; NEUTROPHILS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; VOCAL CORDS;

EID: 50049131943     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-1721. (Pubitemid 35447900)
2. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemière C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27(3):483-494. (Pubitemid 43372521)
3. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda MD: National Institutes of Health, National Asthma Education and Prevention Program; 2007. NIH Publication No. 08-4051. Available from http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Accessed February 12, 2008.
4. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368(9537):804-813. (Pubitemid 44279058)
5. Stedman's Medical Dictionary 27th Edition.
6. Global Initiative For Asthma: Global Strategy for Asthma Management and Prevention (GINA) Bethesda: National Institute of Health, National Heart, Lung, and Blood Institute 2006.
7. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE; GOAL Investigators Group. Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170(8):836-844. (Pubitemid 39346477)
8. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE; TENOR Study Group. Severity assessment in asthma: An evolving concept. J Allergy Clin Immunol 2005;116(5):990-995. (Pubitemid 41571777)
9. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998;53(4): 315-321. (Pubitemid 28215795)
10. Barreiro E, Gea J, Sanjuás C, Marcos R, Broquetas J, Milic-Emili J. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J 2004;24(2):219-225. (Pubitemid 39139788)
11. Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, Takishima T. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330(19):1329-1334. (Pubitemid 24136055)
12. Miles J, Cayton R, Ayres J. Atopic status in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1995; 25(11):1074-1082.
13. Ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005;26(5):812-818. (Pubitemid 41632037)
14. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160(3):1001-1008. (Pubitemid 29442043)
15. Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007;62(6): 475-482. (Pubitemid 46910124)
16. Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med 2004; 10(1):44-50. (Pubitemid 38045900)
17. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodeling in asthma. Chest 2003; 123(3 Suppl):417S-422S. (Pubitemid 36315442)
18. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58(4):322-327. (Pubitemid 36411418)
19. Jang AS, Lee JH, Park SW, Park JS, Kim DJ, Park CS. Risk factors related to fixed airway obstruction in patients with asthma after anti-asthma treatment. Ann Allergy Asthma Immunol 2007;99(5): 408-412. (Pubitemid 350086198)
20. Bumbǎcea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004;24(1):122-128. (Pubitemid 39029077)
21. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006;117(3):522-543. (Pubitemid 43340215)
22. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113(1):101-108. (Pubitemid 38096168)
23. Hsu JY, King SL, Kuo BI, Chiang CD. Age of onset and the characteristics of asthma. Respirology 2004;9(3):369-372. (Pubitemid 39382121)
24. Nowak D. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Respir Med 2006;100(11): 1907-1917. (Pubitemid 44490273)
25. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999;20(11):528-533. (Pubitemid 29507098)
26. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154(5):1497- 1504.
27. Banks DE, Jalloul A. Occupational asthma, work-related asthma and reactive airways dysfunction syndrome. Curr Opin Pulm Med 2007; 13(2):131-136. (Pubitemid 46175110)
28. Boulet LP, Lemière C, Gautrin D, Cartier A. New insights into occupational asthma. Curr Opin Allergy Clin Immunol 2007;7(1): 96-101.
29. Samter M, Beers RF Jr. Intolerance to aspirin Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68(5):975-983.
30. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111(5):913-921. (Pubitemid 36570845)
31. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328(7437):434.
32. Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs 2004;64(21): 2417-2432. (Pubitemid 39472629)
33. Vrieze A, Postma DS, Kerstjens HA. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol 2003; 112(2):271-282. (Pubitemid 36981366)
34. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996;156(16):1837-1840. (Pubitemid 26295229)
35. Zimmerman JL, Woodruff PG, Clark S, Camargo CA. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med 2000;162(2 Pt 1):512-515. (Pubitemid 30647192)
36. Brenner BE, Holmes TM, Mazal B, Camargo CA Jr. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax 2005;60(10):806-809. (Pubitemid 41475203)
37. Martinez-Moragón E, Plaza V, Serrano J, Picado C, Galdiz JB, López-Viña A, Sanchis J. Near-fatal asthma related to menstruation. J Allergy Clin Immunol 2004;113(2):242-244. (Pubitemid 38210544)
38. Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest 2005;128(6):3966-3974. (Pubitemid 43062659)
39. Anderson SD. How does exercise cause asthma attacks? Curr Opin Allergy Clin Immunol 2006;6(1):37-42.
40. Green RH, Brightling CE, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol 2007; 7(1):43-50. (Pubitemid 46095885)
41. Pavord ID, Sterk PJ, Hargreave FE, Kps JC, Inman MD, Louis R, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl 2002;37:40S-43S. (Pubitemid 35024265)
42. Lemière C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 2006;118(5):1033-1039.
43. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005;171(10):1077-1082. (Pubitemid 40663717)
44. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004; 170(6):601-605. (Pubitemid 39202200)
45. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57(10):875-879. (Pubitemid 35178612)
46. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119(5):1043-1052. (Pubitemid 46654194)
47. Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007;120(4):855-864.
48. Tilles SA. Differential diagnosis of adult asthma. Med Clin North Am 2006;90(1):61-76. (Pubitemid 41682031)
49. Silverman M, Anderson SD. Standardization of exercise tests in asthmatic children. Arch Dis Child 1972;47(256):882-889.
50. Tinkelman DG, Price DB, Nordyke RJ, Halbert RG, Isonaka S, Nonikov D, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006;73(3):296-305. (Pubitemid 43725786)
51. Meslier N, Racineux JL, Six P, Lockhart A. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J 1989;2(6):497-505. (Pubitemid 19170579)
52. Cockcroft DW, Swystun VA Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98(6 Pt 1):1016-1018. (Pubitemid 27014791)
53. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984;39(12): 912-918. (Pubitemid 15211828)
54. Boro AK, Sharma SK, Pande JN Comparison of single breath and steady state methods for the measurement of pulmonary diffusing capacity for carbon monoxide in normal subjects, patients with bronchial asthma and chronic obstructive airway disease. Indian J Chest Dis Allied Sci 1992;34(1):1-5.
55. Collard P, Njinou B, Nejadnik B, Keyeux A, Frans A. Single breath diffusing capacity for carbon monoxide in stable asthma. Chest 1994; 105(5):1426-1429. (Pubitemid 24152598)
56. Sterk PJ, Bel EH. The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143(6):1433-1437.
57. Polosa R, Rorke S, Holgate ST. Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 2002;57(7):649-654. (Pubitemid 34761770)
58. Kurashima K, Takayanagi N, Sato N, Kanauchi T, Hoshi T, Tokunaga D, et al. High resolution CT and bronchial reversibility test for diagnosing COPD. Respirology 2005;10(3):316-322. (Pubitemid 41025609)
59. Bellia V, Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, Rengo F. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003;123(4):1066-1072. (Pubitemid 36444362)
60. Sin BA, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol 2006;16(1):44-50.
61. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167(3):418-424. (Pubitemid 36216426)
62. Ibrahim WH, Gheriani HA, Almohamed AA, Raza T. Paradoxical vocal cord motion disorder: past, present and future. Postgrad Med J 2007;83(977):164-172. (Pubitemid 46465519)
63. Morris MJ, Deal LE, Bean DR, Grbach VX, Morgan JA. Vocal cord dysfunction in patients with exertional dyspnea. Chest 1999;116(6): 1676-1682. (Pubitemid 30012712)
64. Heiser JM, Kahn ML, Schmidt TA. Functional airway obstruction presenting as stridor: a case report and literature review. J Emerg Med 1990;8(3):285-289. (Pubitemid 20324684)
65. Myears DW, Martin RJ, Eckert RC, Sweeney MK. Functional versus organic vocal cord paralysis: rapid diagnosis and decannulation. Laryngoscope 1985;95(10):1235-1237. (Pubitemid 16228726)
66. Newman KB, Mason UG III, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995;152(4 Pt 1):1382-1386.
67. Jain S, Bandi V, Officer T, Wolley M, Guntupalli KK. Role of vocal cord function and dysfunction in patients presenting with symptoms of acute asthma exacerbation. J Asthma 2006;43(3):207-212. (Pubitemid 43879414)
68. O'Connell MA, Sklarew PR, Goodman DL. Spectrum of presentation of paradoxical vocal cord motion in ambulatory patients. Ann Allergy Asthma Immunol 1995;74(4):341-344.
69. Sullivan MD, Heywood BM, Beukelman DR. A treatment for vocal cord dysfunction in female athletes: an outcome study. Laryngoscope 2001;111(10):1751-1755. (Pubitemid 32946448)